title: Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
abstract: Anti-tumor necrosis factor (anti-TNF) agents have been successfully used to treat both chronic idiopathic inflammatory bowel disease and other immune-mediated chronic diseases, but they can also induce a wide array of cutaneous reactions, including new-onset psoriasis and alopecia. We report a case of alopecia associated with psoriasiform skin lesions in a patient on adalimumab treatment for Crohn's disease.
authors.affiliation: Department of Dermatology, Santarem Hospital, Santarem. helenatoda@gmail.com.
authors.forename: H
authors.initials: H
authors.lastname: Toda-Brito
authors.forename: L
authors.initials: L
authors.lastname: Lopes
authors.forename: L
authors.initials: L
authors.lastname: Soares-Almeida
authors.forename: P
authors.initials: P
authors.lastname: Filipe
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects*; D000506:Alopecia Areata / Q000139:chemically induced* / Q000473:pathology; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab